Stereotactic body radiotherapy (SBRT) has emerged as a non-invasive alternative for the treatment of adrenal metastases, increasingly replacing traditional invasive approaches. However, its clinical application remains under investigation. The introduction of advanced radiotherapy techniques has further fueled interest in SBRT, necessitating comprehensive dosimetric evaluations to optimize treatment strategies. This study compares three distinct SBRT techniques: pure intensity-modulated radiotherapy (IMRT), pure volumetric modulated arc therapy (VMAT), and a hybrid approach combining VMAT and IMRT, utilizing flattening filter-free (FFF) photon beams. Treatment plans were assessed using dosimetric distributions, dose-volume histograms (DVH), homogeneity index (HI), and conformity index (CI). Repeated-measures analysis of variance (ANOVA) was performed, with statistical significance set at p < 0.05. Both VMAT and hybrid plans demonstrated superior CI and HI values compared to IMRT. However, the maximum dose (Dmax) to the planning target volume (PTV) was lower in the hybrid plan than in VMAT but comparable to IMRT. Additionally, critical organ dose analyses revealed that VMAT and hybrid plans achieved significantly lower doses in the renal cortex (Dmax and V17.5), duodenum (Dmax and V12.5), aorta (Dmax), and stomach (Dmax) compared to IMRT. The findings indicate that both VMAT and hybrid techniques outperform IMRT, offering improved plan quality and superior critical organ sparing. These results highlight the potential clinical advantages of VMAT and hybrid SBRT approaches in the treatment of adrenal metastases. Further clinical validation through large-scale studies is warranted to establish the optimal treatment strategy.
Objective: This study aimed to explore the stigma experiences of male breast cancer patients, a group often overlooked due to the rarity of the disease. This research focuses on how these patients perceive and are affected by social stigma during and after treatment. Method: A qualitative phenomenological approach was adopted. The study included five male patients diagnosed with breast cancer, recruited from an oncology hospital in Central Anatolia, Turkey, between January and October 2023. Data were collected through semistructured interviews conducted via WhatsApp video calls. All interviews were audio‐recorded, transcribed verbatim, and analyzed thematically. The study followed the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist. Results: Participants initially attempted to hide the physical signs of their illness but later adapted to their condition. Challenges were reported in resuming normal life during and after treatment, including surgery, chemotherapy, and radiotherapy. While no significant stigma was perceived within hospital settings, participants expressed discomfort about receiving treatment in shared environments with female patients, particularly in waiting areas. These feelings were linked to gender roles and social perceptions. Conclusion: Although male breast cancer patients did not report stigma from healthcare professionals, they experienced emotional discomfort due to the predominantly female environment of breast cancer care. The findings emphasize the need to raise awareness of male breast cancer and to create healthcare environments sensitive to gender‐based experiences to support the psychosocial well‐being of male patients.
30 September 2026 in Journal of Basic and Clinical Health Sciences
Purpose: Recombinant activated protein C (rAPC) is widely regarded as an anti-inflammatory and cytoprotective agent; however, its molecular effects in the irradiated central nervous system remain poorly characterized. This study aims to characterize the gene expression profile triggered by rAPC in the rat brain and to evaluate how ionizing radiation alters these molecular (apoptotic and neuroinflammatory) responses.Material and Methods: Male Wistar Albino rats were randomly assigned to four experimental groups: untreated control, total body irradiation (9 Gy, TBI), rAPC (0.4 mg/kg, intravenous) alone, and TBI followed by rAPC. Brain tissue was collected for gene expression analysis of apoptosis, neuroinflammation, and oxidative stress-related markers.Results: Five genes showed significant omnibus effects. BAX expression (ε² = 0.62) was significantly reduced by both irradiation and rAPC alone; the combination group showed higher BAX than the irradiation-only group, suggesting partial restoration by rAPC. BCL-2 was reduced by irradiation and p53 was reduced by rAPC alone (η² = 0.38). Strikingly, rAPC alone selectively upregulated NLRP3 inflammasome expression (p = 0.023) with a consistent directional increase in TNF-α, a pro-inflammatory activation signature absent in irradiated groups. No significant changes were observed in oxidative stress markers, COX-2, FGFR, or CASP3. Conclusion: These findings reveal a radiation-sensitive molecular phenotype for rAPC in rat brain tissue. rAPC alone upregulates Nlrp3 expression and associated signaling while simultaneously reducing P53 and Bax expression, defining a multifaceted molecular profile that is substantially modified in the irradiated context.
Purpose: To evaluate the dosimetric properties of the deep inspiration breath hold (DIBH) technique adapted to tangential-based volumetric modulated arc therapy (TVMAT) in left breast cancer patients with mastectomy. Method: Forty-three patients who underwent mastectomy and received chest wall and regional lymph node irradiation were included in the study. Simulation computed tomography (CT) was performed in DIBH and free-breathing (FB). Two plans were created for each patient; DIBH-TVMAT and FB-TVMAT. Both plans were realized using a mono-isocentric technique with two partial arc rotations, and the same gantry angles were used.The standard fractionation schedule for each patient was set to 50 Gy in 25 fractions. Paired-sample T-test was used to evaluate the dosimetric parameters. Results: The comparison between FB-TVMAT and DIBH-TVMAT plans revealed mean heart doses of 8.9 Gy and 5.4 Gy, respectively (p=0.000). A 6.2% reduction was encountered in left lung volume receiving 5 Gy (V5) in the DIBH-TVMAT plan (p=0.01). A reduction of 1.3 Gy at a percentage of 28% was monitored in the mean dose of the right lung in DIBH-TVMAT (p=0.000). The mean right breast dose was 0.7 Gy lower in DIBH-TVMAT (p=0.000). Conclusion: The results support that the adaptation of DIBH to TVMAT allows an optimal target volume dose coverage as well as leads to significant dose reductions in the left lung, right lung, heart, LADCA, and right breast for the left breast cancer patients with mastectomy.
4 November 2024 in Irish Journal of Medical Science (1971 -)